Pharmaceutical Regulatory Database of South American Countries

This database offers organized regulations intelligence information about the different countries within South America regarding their pharmaceutical product approval structure, the various drug regulatory agencies, and frameworks for granting marketing authorization. It collects the key parameters of drug regulations, including approval pathways, clinical trial contents and requirements, pharmacovigilance requirements, GMP standards, and international harmonization status into one cohesive comparative format. The purpose of this dataset is to help regulatory affairs professionals evaluate the feasibility of entering the market of a certain country, fulfil the specific compliance requirements for that specific country, as well as compare the regulatory level of maturity, transparency, and efficiency between jurisdictions.本数据库提供经系统化整理的监管情报信息，涵盖南美洲各国的药品产品审批架构、各类药品监管机构，以及上市许可授予相关框架。本数据库将药品监管的核心参数——包括审批路径、临床试验内容与要求、药物警戒（Pharmacovigilance）要求、药品生产质量管理规范（Good Manufacturing Practice，GMP）标准以及国际协调现状——整合为统一的对比格式。本数据集旨在协助监管事务专业人士评估进入特定国家市场的可行性，满足该国特定的合规要求，同时可用于对比不同司法管辖区的监管成熟度、透明度与效率水平。